Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam ...
Tag: schizophrenia
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
Bristol Myers Squibb's Cobenfy drugCourtesy: Bristol Myers SquibbThe Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated ...
Recent News
